CCP
Clough Capital Partners Portfolio holdings
AUM
$997M
This Quarter Return
+5.44%
1 Year Return
+37.42%
3 Year Return
+130.83%
5 Year Return
+251.5%
10 Year Return
+1,002%
AUM
$928M
AUM Growth
+$928M
(-5.9%)
Cap. Flow
-$85.1M
Cap. Flow
% of AUM
-9.18%
Top 10 Holdings %
Top 10 Hldgs %
24.59%
Holding
191
New
35
Increased
36
Reduced
51
Closed
27
Top Buys
| 1 |
Illumina
ILMN
|
$16.8M |
| 2 |
TSMC
TSM
|
$12.1M |
| 3 |
Johnson & Johnson
JNJ
|
$11.5M |
| 4 |
Wynn Resorts
WYNN
|
$10.9M |
| 5 |
Northrop Grumman
NOC
|
$9.12M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$17.9M |
| 2 |
ICICI Bank
IBN
|
$13.3M |
| 3 |
HDFC Bank
HDB
|
$13.1M |
| 4 |
Starwood Property Trust
STWD
|
$12M |
| 5 |
Texas Instruments
TXN
|
$12M |
Sector Composition
| 1 | Healthcare | 23.46% |
| 2 | Technology | 13.61% |
| 3 | Industrials | 12.55% |
| 4 | Financials | 10.76% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vertex Pharmaceuticals
VRTX
$100B
| $11.5M | 1.24% | 36,521 -10,690 | -23% | -$3.37M |
|
|
27
Wynn Resorts
WYNN
$13.2B
| $10.9M | 1.17% | +96,990 | New | +$10.9M |
|
28
Berkshire Hathaway Class A
BRK.A
$1.09T
| $10.7M | 1.15% | 23 -1 | -4% | -$466K |
|
29
Merck
MRK
$210B
| $10.5M | 1.13% | 98,850 +49,460 | +100% | +$5.26M |
|
30
Procter & Gamble
PG
$368B
| $9.74M | 1.05% | 65,500 | – | – |
|
31
Legend Biotech
LEGN
$6.41B
| $9.7M | 1.05% | 201,236 +162,760 | +423% | +$7.85M |
|
32
Jazz Pharmaceuticals
JAZZ
$7.75B
| $9.43M | 1.02% | 64,410 -20,420 | -24% | -$2.99M |
|
33
Tenet Healthcare
THC
$16.3B
| $9.22M | 0.99% | 155,225 +6,235 | +4% | +$370K |
|
34
Bank of America
BAC
$376B
| $9.06M | 0.98% | 316,740 -80,260 | -20% | -$2.3M |
|
35
Tesla
TSLA
$1.08T
| $8.42M | 0.91% | 40,594 -18,850 | -32% | -$3.91M |
|
36
iShares MSCI China ETF
MCHI
$7.91B
| $8.35M | 0.9% | +167,400 | New | +$8.35M |
|
37
JPMorgan Chase
JPM
$829B
| $8.14M | 0.88% | 62,500 | – | – |
|
|
ACP
38
abrdn Income Credit Strategies Fund
ACP
$745M
| $7.99M | 0.86% | +1,197,397 | New | +$7.99M |
|
39
Palo Alto Networks
PANW
$127B
| $7.97M | 0.86% | 39,895 -50,450 | -56% | -$10.1M |
|
40
Boston Scientific
BSX
$156B
| $7.87M | 0.85% | 157,377 -199,850 | -56% | -$10M |
|
|
ZTR
41
Virtus Total Return Fund
ZTR
$354M
| $7.8M | 0.84% | 1,205,117 +288,880 | +32% | +$1.87M |
|
|
KIO
42
KKR Income Opportunities Fund
KIO
$510M
| $7.8M | 0.84% | +710,115 | New | +$7.8M |
|
43
Select Medical
SEM
$1.61B
| $7.69M | 0.83% | +297,500 | New | +$7.69M |
|
44
Veracyte
VCYT
$2.39B
| $7.58M | 0.82% | 339,978 +23,002 | +7% | +$513K |
|
45
BlackRock Capital Allocation Term Trust
BCAT
$1.57B
| $7.3M | 0.79% | 482,030 +73,330 | +18% | +$1.11M |
|
46
Zimmer Biomet
ZBH
$21B
| $7.27M | 0.78% | 56,270 -44,530 | -44% | -$5.75M |
|
47
Cisco
CSCO
$274B
| $7.23M | 0.78% | 138,400 +96,200 | +228% | +$5.03M |
|
48
Transocean
RIG
$2.86B
| $6.76M | 0.73% | +1,062,843 | New | +$6.76M |
|
49
Qualcomm
QCOM
$173B
| $6.7M | 0.72% | 52,500 +15,400 | +42% | +$1.96M |
|
50
Pfizer
PFE
$141B
| $6.22M | 0.67% | 152,490 +132,890 | +678% | +$5.42M |
|